Lead Pharma Achieves Second Milestone for Development of Autoimmune Diseases Treatments in Sanofi Collaboration
Lead Pharma announced that it has achieved a second milestone under its research collaboration with Sanofi.
Read more
Rob Prins nieuwe voorzitter Raad van Bestuur Pivot Park
Rob Prins vervangt per 1 april Jan Pelle als voorzitter van de Raad van Bestuur van Pivot Park.
Read more
Enterprise System Partners and TraceLink Form Strategic Alliance
Enterprise System Partners announced it has established a strategic partnership with TraceLink.
Read more
New study in Oncotarget shows that stable aneuploid cells are more sensitive to TTK inhibition than chromosomally unstable cell lines
Stable aneuploid tumor cells are more sensitive to small molecule inhibitors of TTK than chromosome instable cells.
Read more
New at Pivot Park: PerkinElmer OneSource
Since mid-February OneSource is a new occupant in the Pivot Park community.
Read more
Regenerative medicine crossing borders
Osteo-Pharma will take part in the five-year project focusing on taking steps towards a bioengineered joint.
Read more
RA2day: addressing today’s regulatory topics
Zwiers Regulatory Consultancy is organising RA2day on April 7th 2017.
Read more
New at Pivot Park: MSD Animal Health
MSD Animal Health, formerly known as Intervet, is one of the companies that became part of the Pivot Park Community.
Read more
PharmSupport betrekt kantoor op Pivot Park
H. Lundbeck A/S (Lundbeck) and Prexton Therapeutics BV (Prexton) announced March 16th the signing of a definitive agreement in which Lundbeck will acquire Prexton.
Read more